How NPY Blocks Vagal Gut-Brain Appetite Signals in the Brainstem | Research

The takeaway

Neuropeptide Y inhibits vagal activation of brainstem catecholamine neurons via presynaptic Y2 receptors, modulating gut-to-brain appetite signaling.

Presynaptic Y2 inhibition
NPY blocks vagal satiety signals before they reach brainstem neurons

What the researchers found

NPY inhibits vagal activation of NTS catecholamine neurons via presynaptic Y2 receptors, providing a mechanism by which NPY modulates gut-derived satiety signaling in the brainstem.

Why it matters

Understanding how appetite signals are modulated in the brainstem reveals potential drug targets for obesity treatment and explains why some people have difficulty feeling full.

How the study worked

Electrophysiology and pharmacology study in mice examining NPY effects on vagal-NTS synaptic transmission, identifying Y2 receptor-mediated presynaptic inhibition of catecholamine neurons.

What this study cannot tell us

Mouse study — human brainstem circuitry may differ. In vitro electrophysiology may not fully reflect in vivo conditions.

How to read the evidence

Mechanistic neuroscience study — provides detailed molecular understanding of a specific appetite-regulatory circuit.

When this study was published

Published in 2026; advances understanding of brainstem appetite control.

The bigger picture

This reveals a specific molecular mechanism within the gut-brain axis that controls appetite, adding precision to our understanding of how the brain decides when to stop eating.

Questions still open

Could Y2 receptor antagonists enhance satiety signaling for obesity treatment?
Does this NPY mechanism explain why GLP-1 drugs, which oppose NPY effects, suppress appetite?

Common questions

What is NPY?

Neuropeptide Y is one of the most potent appetite-stimulating signals in the brain. This study shows it works partly by blocking gut fullness signals in the brainstem, overriding the signal to stop eating.

How does this relate to weight loss drugs?

GLP-1 drugs activate appetite-suppressing pathways that oppose NPY's effects. Understanding how NPY blocks fullness signals helps explain why GLP-1 drugs effectively reduce appetite.

Read the original research

NPY inhibits vagal activation of NTS catecholamine neurons via presynaptic Y2 receptors in mice.

American journal of physiology. Regulatory, integrative and comparative physiology, 330(3), R283-R299

View on PubMed ↗Publisher’s paper ↗

Citation

Calkins, Rowan J; Zhao, Huan; Page, Stephen J; Neyens, Drew M; Appleyard, Suzanne M. (2026). NPY inhibits vagal activation of NTS catecholamine neurons via presynaptic Y2 receptors in mice.. American journal of physiology. Regulatory, integrative and comparative physiology, 330(3), R283-R299. https://doi.org/10.1152/ajpregu.00315.2024